Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Syndax Pharmaceuticals (SNDX) Leases (2019 - 2025)

Syndax Pharmaceuticals (SNDX) has 7 years of Leases data on record, last reported at $1.3 million in Q4 2025.

  • For Q4 2025, Leases fell 35.71% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $1.3 million, down 35.71%, while the annual FY2025 figure was $1.3 million, 35.71% down from the prior year.
  • Leases reached $1.3 million in Q4 2025 per SNDX's latest filing, down from $1.5 million in the prior quarter.
  • Across five years, Leases topped out at $2.0 million in Q4 2024 and bottomed at $338000.0 in Q2 2021.
  • Average Leases over 5 years is $1.2 million, with a median of $1.1 million recorded in 2021.
  • Peak YoY movement for Leases: skyrocketed 238.97% in 2021, then tumbled 56.33% in 2024.
  • A 5-year view of Leases shows it stood at $983000.0 in 2021, then increased by 5.7% to $1.0 million in 2022, then soared by 43.12% to $1.5 million in 2023, then soared by 35.98% to $2.0 million in 2024, then crashed by 35.71% to $1.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Leases were $1.3 million in Q4 2025, $1.5 million in Q3 2025, and $1.6 million in Q2 2025.